真弓忠範 | 大阪大学薬薬剤

スポンサーリンク

概要

関連著者

もっと見る

著作論文

In Vitro and In Vivo Tumor Suppressive Activity Induced by Human Telomerase Transcriptase-Targeting Antisense Oligonucleotides Mediated by Cationic Liposomes(CELL AND TISSUE ENGINEERING)
Cell-Penetrating Peptides as Adenovirus Vector Carrier
Creation of Novel Cell-Penetrating Peptides for Intracellular Drug Delivery Using Systematic Phage Display Technology Originated from Tat Transduction Domain(Biochemistry)
Non-Methylated CpG Motif Packaged into Fusogenic Liposomes Enhance Antigen-Specific Immunity in Mice(Highlighted paper selected by Editor-in-chief,Pharmacology)
Vaccine Efficacy of Fusogenic Liposomes Containing Tumor Cell-Lysate against Murine B16BL6 Melanoma(Pharmacology)
Anti-tumor Responses Induced by Chemokine CCL19 Transfected into an Ovarian Carcinoma Model via Fiber-Mutant Adenovirus Vector(Biopharmacy)
Fusogenic Liposome can be Used as an Effective Vaccine Carrier for Peptide Vaccination to Induce Cytotoxic T Lymphocyte (CTL) Response(Biopharmacy)
プロテオーム創薬にかなう機能性人工蛋白質の迅速創出とそのPEGylationへの展開 (化学と生物学の接点がつくるNewバイオテクノロジー) -- (蛋白質の修飾をコントロールする)
蛋白療法の最適化にかなうあらたな薬物送達戦略 (ナノテクノロジー創薬--DDSの新展開)
My Technology 医薬価値に優れた機能性人工タンパク質の網羅的かつ迅速同定システムとプロテオーム創薬への展開
ケモカイン及びサイトカイン発現アデノウイルスベクターの併用による癌遺伝子治療の最適化
目的とする生理活性を完全に保持した機能性変異蛋白質の迅速構築とそのDDSへの応用
ファージディスプレイシステムを利用した部位特異的PEGylation
Development of Novel Drug Delivery System (DDS) Technologies for Proteomic-Based Drug Development
Selective Enhancer of Tumor Vascular Permeability for Optimization of Cancer Chemotherapy (Pharmacognosy)
Neutralizing Antibody Evasion Ability of Adenovirus Vector Induced by the Bioconjugation of Methoxypolyethylene Glycol Succinimidyl Propionate(MPEG-SPA)(Biopharmacy)
Anti-angiogenic Effects of Dimethyl Sulfoxide on Endothelial Cells(Pharmacognosy)
細胞内薬物動態制御を目指した機能性ナノ粒子の細胞質内導入(DDSとナノ粒子)
Preparation and Biological Activities of a Bivalent Poly(Ethylene Glycol) Hybrid Containing an Active Site and Its Synergistic Site of Fibronectin
ファージ表面提示法を駆使した機能性人工蛋白質の創出とDDSへの展開

もっと見る

スポンサーリンク